Trials / Completed
CompletedNCT02566525
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- CytoSorbents, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multi-center, randomized, feasibility clinical study. Subjects will be randomized in a 1:1 ratio to either standard of care (SOC) alone or standard of care and treatment with the CytoSorb® device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytoSorb | Cytosorb device use during cardiopulmonary bypass |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2015-10-02
- Last updated
- 2021-08-20
- Results posted
- 2021-08-20
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02566525. Inclusion in this directory is not an endorsement.